Clear Labs PM and reagents for FY26 Sole Source

Closed State & local contract opportunity Posted

Solicitation number
25-482DPH-OFCDI-B-49031
State
Illinois
Responses due

Opportunity facts

UNSPSC codes
Show all 46
Point of contact

Opportunity details come from bidbuy.illinois.gov. Updated .

About this opportunity

Written by GovTribe AI ·

The Illinois Department of Public Health (IDPH), specifically the Division of Laboratories, is seeking a sole source contract with Clear Labs, Inc. for service coverage, reagents, and consumables for two Clear Dx System LR-SR instruments. The procurement includes two Clear Dx System Service Plans, 110 Clear Dx WGS SARS-CoV-2 Reagent v3.0 and Automation Bundles, and 195 Clear Dx Microbial Surveillance WGS Reagent v2.0 and Automation Bundles. The contract is for a one-year term from December 6, 2025, to December 5, 2026, with no potential renewals. The primary objective is to maintain a next-generation sequencing platform for molecular testing and genomic analysis in public health surveillance. Clear Labs is the sole manufacturer and authorized supplier of this system in the United States, offering a unique platform with integrated automation, time-efficient whole genome sequencing, and a closed workflow that minimizes manual sample handling. The deadline for submitting written comments or requesting a public hearing is Friday, September 19th, 2025, at 4 p.m.

The contract is a sole source procurement, effectively limiting competition to Clear Labs, Inc. There are no specific set-aside designations or restrictions on organizational types mentioned in the documentation. The contract will be funded through federal funds, with a total contract value of $859,656. The Clear Dx Platform is positioned as a specialized next-generation sequencing solution for public health officials, epidemiologists, and healthcare providers, enabling rapid, real-time genomic surveillance decisions with minimal labor requirements. The system includes multiple configurations and supports various testing scenarios, including microbial identification and SARS-CoV-2 testing. No incumbent vendors are mentioned, as this appears to be a continuation of an existing technological infrastructure specific to Clear Labs' proprietary system. The procurement emphasizes the unique capabilities of the Clear Dx Platform and the inability of alternative vendors to provide compatible components or support services.

Opportunity text

This is a notice of intent to award a contract as a sole source to Clear Labs for service coverage for two Clear Dx System LR-SR instruments and Clear Dx System reagents and consumables. See attachment for details. The hearing will be canceled unless an interested party submits written comments or makes a written request for public hearing by Friday, September 19th 2025 at 4 p.m. to the Info Contact above.

Files

File Type Posted
11. Sole Source Justification Form 1 Clear Labs Annual Reagent Service SS 68500001M MC.pdf PDF
8. Sole Source Memo Clear Labs Annual Reagents and Service SS 68500001M.pdf PDF
Sole Source Hearing Clear Labs Service SS 68500001M~1.pdf PDF
CPO signed part I and II DPH B-49031.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Similar opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login